Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
38.02
-0.91 (-2.34%)
At close: Oct 2, 2026, 4:00 PM EDT
37.58
-0.44 (-1.16%)
After-hours: Oct 2, 2026, 7:32 PM EDT
Xenon Pharmaceuticals Employees
As of December 31, 2025, Xenon Pharmaceuticals had 370 total employees, including 358 full-time and 12 part-time employees. The number of employees increased by 43 or 13.15% compared to the previous year.
Employees
370
Change (1Y)
43
Growth (1Y)
13.15%
Revenue / Employee
n/a
Profits / Employee
-$1,105,932
Market Cap
3.68B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 370 | 43 | 13.15% | 358 | 12 |
| Dec 31, 2024 | 327 | 68 | 26.25% | 316 | 11 |
| Dec 31, 2023 | 259 | 46 | 21.60% | 251 | 8 |
| Dec 31, 2022 | 213 | 60 | 39.22% | 203 | 10 |
| Dec 31, 2021 | 153 | 24 | 18.60% | 149 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| Acadia Pharmaceuticals | 798 |
| Tarsus Pharmaceuticals | 370 |
| Relay Therapeutics | 202 |
| Celcuity | 155 |
| Parabilis Medicines | 145 |
| IDEAYA Biosciences | 145 |
XENE News
- 1 day ago - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 days ago - Xenon Pharmaceuticals CFO buys 15,000 shares - TheFly
- 3 days ago - Xenon Pharmaceuticals CEO buys 30,000 shares - TheFly
- 5 days ago - Defence Therapeutics Appoints Finance Executive Sherry Aulin to Its Board of Directors - Newsfile Corp
- 10 days ago - Xenon Pharmaceuticals Transcript: TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit - Transcripts
- 11 days ago - XENE Investors Have Opportunity to Join Xenon Pharmaceuticals Inc. Fraud Investigation with SBS Law - Business Wire
- 11 days ago - Xenon Pharmaceuticals Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Xenon Pharmaceuticals (XENE) - PRNewsWire
- 12 days ago - Wolf Popper LLP Announces Investigation on Behalf of Xenon Pharmaceuticals Inc. Investors - GlobeNewsWire